ACET

Companies
NASDAQ
Adicet Bio, Inc.
Health Care
Price Chart
Overview

About ACET

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Market Cap
$110.9M
Volume
307.3K
Avg. Volume
272.1K
P/E Ratio
-0.4817293
Dividend Yield
0.00%
Employees
137.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.39
High Correlation
Volatility
High (0.77)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ACET.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ACET shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$110.9M
Volume307.3K
P/E Ratio-0.48
Dividend Yield0.00%
Important Dates
Next Dividend
September 16, 2020
Next Earnings
March 7, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how ACET fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025